GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Profitability Rank

China Isotope & Radiation (HKSE:01763) Profitability Rank : 8 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Profitability Rank?

China Isotope & Radiation has the Profitability Rank of 8. It has a higher profitability and may stay that way.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is rated on a scale of 1 to 10 and is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

China Isotope & Radiation's Operating Margin % for the quarter that ended in Jun. 2024 was 14.67%. As of today, China Isotope & Radiation's Piotroski F-Score is 5.


Competitive Comparison of China Isotope & Radiation's Profitability Rank

For the Medical Devices subindustry, China Isotope & Radiation's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's Profitability Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Profitability Rank distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's Profitability Rank falls into.


;
;

China Isotope & Radiation Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The rank is rated on a scale of 1 to 10. A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

China Isotope & Radiation has the Profitability Rank of 8. It has a higher profitability and may stay that way.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

China Isotope & Radiation's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=443.746 / 3025.388
=14.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

China Isotope & Radiation has an F-score of 5 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

China Isotope & Radiation Corp operating margin has been in a 5-year decline. The average rate of decline per year is -6.4%.

4. Consistency of the profitability

5. Predictability Rank


China Isotope & Radiation Profitability Rank Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
Executives
Ubs Group Ag 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Li Hongbo 2201 Interest of corporation controlled by you
Lianwen Ltd 2101 Beneficial owner
Invesco Advisers, Inc. 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Invesco Hong Kong Limited 2102 Investment manager
Invesco Corporate Class Inc. 2106 Person having a security interest in shares
M&g Plc 2201 Interest of corporation controlled by you
Shanghai Industrial Holdings Limited 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Serenity Investment Master Fund Limited 2101 Beneficial owner
Serenity Capital Management, Ltd. 2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd. 2201 Interest of corporation controlled by you
S.i. Infrastructure Holdings Limited 2201 Interest of corporation controlled by you

China Isotope & Radiation Headlines

No Headlines